022 24172311
Sections
Search
Subscribe
DealCurry
Equity
Venture Capital
Private Equity
M&A

Private Equity | 8 September 2010

Actis, Sequoia Plan Stake Sale In Paras Pharma For $700 Mn

by Deeshesh Chheda
Actis, Sequoia Plan Stake Sale In Paras Pharma For $700 Mn
Share on Social Media Email Facebook Twitter Linkedin
 
@deeshesh

Private equity firms Actis Capital and Sequoia Capital are planning to sell a controlling stake in FMCG company Paras Pharmaceuticals Limited for $700 million.

The private equity firms decided to sell their shares after receiving interest from drugmakers including GlaxoSmithKline, Sanofi-Aventis and Abbott Laboratories.

Actis, a private equity firm that invests in emerging markets, holds about 62% in Paras and Sequoia holds about 8%, while Paras Chairman Girish Patel and employees own the remaining stake.

Transaction Reference: BS


{TAG_9638_1283930409}

Century Real Estate Raises Rs 100 Cr Via NCDs

Century Real Estate Raises Rs 100 Cr Via NCDs

Century Real Estate Holdings, the real estate arm of the Century Group has raised Rs.100 crore though private placement of NCDs last week.

Read More...

Rajeswari Infra Seeks FDI For Chennai Project

Rajeswari Infra Seeks FDI For Chennai Project

Rajeswari Infrastructure is planning to raising $5 Mn in FDI for its new residential projects in Chennai - Trillium.

Read More...